Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Uridine Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111018844B reveals a novel 3-step synthesis of sofosbuvir key intermediates from uridine, offering significant cost reduction and improved chiral purity for API manufacturing.
Patent CN105503742A reveals visible light photocatalysis for high-yield difluoroalkyl uracil synthesis offering supply chain stability and cost efficiency for pharmaceutical manufacturing.